Email Us
"
About Sungen

Sungen Biomedical was founded in 2019 which is an innovative antibody drug research and development enterprise incubated by Hotgen Biotech (SH688068), a listed company on the Shanghai Stock Exchange. The co-founder of Sungen Biomedical is Professor Zhiwei Sun, Vice Chairman of China Monoclonal Antibody Industry Committee.

Learn More About Us
bio medical tech company
"
What Does Sungen Achieve?

Sungen Biomedical, founded in 2019 and incubated by Hotgen Biotech, specializes in innovative antibody drugs and large molecule biopharmaceuticals. With a robust R&D pipelines, cutting-edge technology platforms, and strategic collaborations, we are committed to advancing medical science and improving patient outcomes globally.

Explore Sungen Research Innovation
Components of Antibody Drug Conjugates
Apr
15
Components of Antibody Drug Conjugates
Introduction to Antibody Drug ConjugatesMalignant tumors have become the second largest health threat worldwide. However, most chemotherapy drugs have a low therapeutic index and commonly cause seriou...
Read article >
The Mechanism of Action of Bispecific Antibody Therapy
Apr
07
The Mechanism of Action of Bispecific Antibody Therapy
Introduction to Bispecific Antibody TherapySo far, compared with traditional cancer treatment strategies, immunotherapy is considered the most promising systemic tumor treatment method. Among them, mo...
Read article >
The Role and Development Trends of Antibody Drugs
Mar
30
The Role and Development Trends of Antibody Drugs
The Role of Antibody DrugsThe greatest challenge in cancer treatment is to eradicate cancer cells while minimizing the loss of normal cells. To address this challenge, targeted therapies have been dev...
Read article >
LEAVE US A MESSAGE
LEAVE US A MESSAGE
Do you want to know Innovation in Medical Technology? Contact our experts to help you!
Quick Links
Email
sungen@sungenbiomed.com.cn
Tel
+86 01050986588
Address
No.55 Qingfeng West Road, Daxing District, Beijing, China